Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pfitzner

Showing results (411-420 of 427) with videos related to

Pageof 43
Sort By:
Cancers|September 14, 2024
Enhancing Preoperative Outcome Prediction: A Comparative Retrospective Case-Control Study on Machine Learning versus the International Esodata Study Group Risk Model for Predicting 90-Day Mortality in Oncologic EsophagectomyAxel Winter, Robin P van de Water, Bjarne Pfitzner, et al.
International Journal of Surgery (London, England)|November 4, 2025
Overcoming the data barrier: transfer learning for 90-day mortality prediction in general surgery - a retrospective multicenter development and comparison studyAxel Winter, Bjarne Pfitzner, Robin P van de Water, et al.
The ISME Journal|June 7, 2014
Distinct signatures of host-microbial meta-metabolome and gut microbiome in two C57BL/6 strains under high-fat dietAlesia Walker, Barbara Pfitzner, Susanne Neschen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2016
Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast CancerBarbara Ingold Heppner, Michael Untch, Carsten Denkert, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 23, 2017
Clinical relevance and concordance of HER2 status in local and central testing-an analysis of 1581 HER2-positive breast carcinomas over 12 yearsBerit M Pfitzner, Bianca Lederer, Judith Lindner, et al.
Cancers|September 10, 2021
Landscape of Biomarkers and Actionable Gene Alterations in Adenocarcinoma of GEJ and Stomach-A Real World Data AnalysisLouisa Hempel, Julia Veloso de Oliveira, Andreas Gaumann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2014
Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapyJ L Lindner, S Loibl, C Denkert, et al.
Nature|July 12, 2019
Structure and assembly of the mitochondrial membrane remodelling GTPase Mgm1Katja Faelber, Lea Dietrich, Jeffrey K Noel, et al.
Breast Cancer Research and Treatment|May 9, 2019
Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII + IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trialCarsten Denkert, Jan Budczies, Meredith M Regan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2014
PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancerSibylle Loibl, Gunter von Minckwitz, Andreas Schneeweiss, et al.
Pageof 43

Showing results (411-420 of 427) with videos related to

Sort By:
Pageof 43
Cancers|September 14, 2024
Enhancing Preoperative Outcome Prediction: A Comparative Retrospective Case-Control Study on Machine Learning versus the International Esodata Study Group Risk Model for Predicting 90-Day Mortality in Oncologic EsophagectomyAxel Winter, Robin P van de Water, Bjarne Pfitzner, et al.
International Journal of Surgery (London, England)|November 4, 2025
Overcoming the data barrier: transfer learning for 90-day mortality prediction in general surgery - a retrospective multicenter development and comparison studyAxel Winter, Bjarne Pfitzner, Robin P van de Water, et al.
The ISME Journal|June 7, 2014
Distinct signatures of host-microbial meta-metabolome and gut microbiome in two C57BL/6 strains under high-fat dietAlesia Walker, Barbara Pfitzner, Susanne Neschen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2016
Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast CancerBarbara Ingold Heppner, Michael Untch, Carsten Denkert, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 23, 2017
Clinical relevance and concordance of HER2 status in local and central testing-an analysis of 1581 HER2-positive breast carcinomas over 12 yearsBerit M Pfitzner, Bianca Lederer, Judith Lindner, et al.
Cancers|September 10, 2021
Landscape of Biomarkers and Actionable Gene Alterations in Adenocarcinoma of GEJ and Stomach-A Real World Data AnalysisLouisa Hempel, Julia Veloso de Oliveira, Andreas Gaumann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2014
Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapyJ L Lindner, S Loibl, C Denkert, et al.
Nature|July 12, 2019
Structure and assembly of the mitochondrial membrane remodelling GTPase Mgm1Katja Faelber, Lea Dietrich, Jeffrey K Noel, et al.
Breast Cancer Research and Treatment|May 9, 2019
Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII + IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trialCarsten Denkert, Jan Budczies, Meredith M Regan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2014
PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancerSibylle Loibl, Gunter von Minckwitz, Andreas Schneeweiss, et al.
Pageof 43